Press Release

Intranasal immunization with Intravacc’s experimental whooping cough vaccine confers broad protection Bilthoven, The Netherlands, 22 June 2020 – Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and bacterial vaccines, today announced promising results of a preclinical study with its experimental whooping cough vaccine in…

Press Release

Intravacc and Versatope sign research service agreement to develop universal influenza vaccine based on OMV technology Bilthoven, The Netherlands, Lowell, Mass., USA, June 8 2020 – Intravacc, one of the leading translational research and development vaccine institutes with an extensive track record in developing viral and bacterial vaccines and Versatope, a U.S. biotechnology company developing…

Press Release

Intravacc partners with Wageningen Bioveterinary Research and Utrecht University to develop an intranasal COVID-19 vaccine Bilthoven, Lelystad and Utrecht, The Netherlands, 4 June 2020 – Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, has announced more details on its development…